A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug. Biogen said Thursday ...

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked. Among a group ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Like many advisers, Daugs encourages clients to designate a "trusted contact" - and to do so before they experience a health issue. Having one or more such contacts on file enables a financial planner ...

November is Alzheimer's Awareness Month and 7 News met Grand Island couple Tom and Michele Drabik, who shared their experience with the disease.

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Older adults whose cholesterol levels fluctuate from year to year may face an increased risk for dementia and cognitive ...

The Covenant Cafe, an early stage Alzheimer’s activity group, will be held on Tuesday, Nov. 19, from 1-3 p.m., at Covenant United Methodist Church, 44 W. Main St., Lock Haven. David Bellomo, Community ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Daytime tiredness is a potential early sign of a dementia diagnosis in the future, according to a new study. The study, ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...